Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies

BACKGROUND: Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) report difficulty with sleep. METHODS: We examined the effect of omalizumab on sleep-related outcomes during 3–6 months omalizumab or placebo treatment and a 16-week follow-up period within three Phase III double-blind rand...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Transl Allergy
Autors principals: Gimenéz-Arnau, Ana M., Spector, Sheldon, Antonova, Evgeniya, Trzaskoma, Benjamin, Rosén, Karin, Omachi, Theodore A., Stull, Donald, Balp, Maria-Magdalena, Murphy, Thomas
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4989527/
https://ncbi.nlm.nih.gov/pubmed/27540466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-016-0120-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars